WOONSOCKET, R.I., Sept. 24, 2021 /PRNewswire/ -- CVS Health
(NYSE: CVS) today announced that, following approval from the
Centers for Disease Control and Prevention (CDC) based on guidance
from the organization's Advisory Committee on Immunization
Practices (ACIP), select CVS Pharmacy and MinuteClinic locations
are now offering the Pfizer-BioNTech COVID-19 booster shot to
eligible populations beginning today, Friday, September 24.
Following guidelines set by ACIP and CDC:
- People 65 years and older and residents in long-term care
settings should receive a booster shot of Pfizer-BioNTech's
COVID-19 vaccine at least 6 months after their Pfizer-BioNTech
primary series
- People aged 50 to 64 with certain underlying medical conditions
should receive a booster shot of Pfizer-BioNTech's COVID-19
vaccine at least 6 months after their Pfizer-BioNTech primary
series
- People 18 to 49 who are at high risk for severe COVID-19 due to
certain underlying medical conditions may receive a booster
shot of Pfizer-BioNTech's COVID-19 vaccine at least 6 months after
their Pfizer-BioNTech primary series, based on their individual
benefits and risk
- People aged 18-64 years who are at increased risk for COVID-19
exposure and transmission because of occupational or institutional
setting may receive a booster shot of Pfizer-BioNTech's
COVID-19 vaccine at least 6 months after their Pfizer-BioNTech
primary series
Individuals who initially received the Moderna or Johnson &
Johnson (Janssen) COVID-19 vaccine are not eligible for a booster
at this time, per guidance from the public health agencies.
"We have the experience and the infrastructure to play a leading
role in administering booster shots to eligible populations," said
Troyen A. Brennan, M.D., MPH, Executive Vice President and Chief
Medical Officer of CVS Health. "We also continue to make it as
convenient as possible for the unvaccinated to receive their first
doses."
Individuals interested in receiving the Pfizer-BioNTech COVID-19
booster or their initial vaccine series are strongly encouraged to
make an appointment at CVS.com or MinuteClinic.com to ensure they
are able to access the correct vaccine at a convenient time and
location.
Currently, each participating CVS Pharmacy and MinuteClinic
location is offering either the Pfizer-BioNTech, Moderna, or
Johnson & Johnson (Janssen)
vaccine, not all three.
When scheduling an appointment on cvs.com, patients will be
asked to provide the manufacturer and date of their last COVID-19
vaccine and will be able to schedule an appointment for a
Pfizer-BioNTech booster dose if they have had two previous doses
with the same vaccine at least six months prior. Per guidance from
the CDC, patients will be asked to self-attest to their eligibility
as defined by the eligibility guidelines, to help reduce barriers
to access for these select populations.
CVS Health has administered more than 34 million COVID-19
vaccines and 32 million COVID-19 tests across the country to-date.
The company has played a prominent role in administering third
doses to the immunocompromised and is prepared to provide booster
shots from other manufacturers, as well as expand vaccine
eligibility to ages 5-11, as soon as authorized to do so by public
health agencies.
About CVS Health
CVS Health is the leading health
solutions company, delivering care in ways no one else can. We
reach more people and improve the health of communities across
America through our local presence, digital channels and our nearly
300,000 dedicated colleagues including more than 40,000 physicians,
pharmacists, nurses, and nurse practitioners. Wherever and whenever
people need us, we help them with their health whether that's
managing chronic diseases, staying compliant with their
medications, or accessing affordable health and wellness services
in the most convenient ways. We help people navigate the health
care system and their personal health care by improving access,
lowering costs and being a trusted partner for every meaningful
moment of health. And we do it all with heart, each and every day.
Learn more at www.cvshealth.com.
Media contact
Matthew
Blanchette
Matthew.Blanchette@cvshealth.com
401-524-6185
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cvs-health-announces-availability-of-pfizer-biontech-booster-shot-to-eligible-populations-301384931.html
SOURCE CVS Health